FDA Adverse Event Injury Summary report: N

GMK-SPHERE FEMORAL COMPONENT CEMENTED SIZE 2+ L

MDR report key: 11884446 · Received May 26, 2021

Report

Report Number
3005180920-2021-00418
Event Type
Injury
Date Received
May 26, 2021
Date of Event
April 26, 2021
Report Date
May 26, 2021
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030862472
PMA / PMN Number
K140826
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 06 MAY 2021: LOT 161665: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 19-APR-2016. EXPIRATION DATE: 2021-04-06. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY OTHER SIMILAR REPORTED EVENT SINCE 2017. ANOTHER DEVICES INVOLVED: BATCH REVIEW PERFORMED ON 06 MAY 2021: GMK-SPHERE 02.12.0313FL TIBIAL INSERT FIXED SPHERE FLEX SIZE 3/11 MM L (K140826)LOT 146603: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 21-JAN-2015. EXPIRATION DATE: 2019-11-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY OTHER SIMILAR REPORTED EVENT SINCE 2017. GMK-SPHERE 02.07.1201L TIBIAL TRAY FIXED CEMENTED SIZE 1 L (K090988) LOT 153502: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 03-NOV-2015. EXPIRATION DATE: 2020-10-12. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY OTHER SIMILAR REPORTED EVENT SINCE 2017.

Description of Event or Problem · 1

THE PATIENT CAME IN REPORTING TIGHTNESS DUE TO THE PRESENCE OF SCAR TISSUE. THE SURGEON REVISED THE FEMORAL COMPONENT, TIBIAL TRAY, AND INSERT 4 YEARS AND 4 MONTHS AFTER PRIMARY. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
782086 GMK-SPHERE FEMORAL COMPONENT CEMENTED SIZE 2+ L FEMORAL COMPONENT CEMENTED JWH MEDACTA INTERNATIONAL SA 02.12.0022L 161665 07630030862472

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention